ABSTRACT Peak expiratory flow rate (PEF) was measured during haemodialysis in 30 unselected patients with chronic renal failure. The patients attended the hospital dialysis unit, where they received regular dialysis using a cuprophan dialyser with acetate buffered dialysate. Mean PEF had fallen by 60 1/min (13%) 30 minutes after the start of dialysis. In 10 of the 30 patients the fall in PEF was over 15%, the maximum fall being 32%. After the initial fall PEF increased throughout the next 2 5 hours of haemodialysis, but it fell again at five hours in the 14 patients who had been dialysed for four hours. During dialysis there was a reduction in blood white cell and platelet counts and in arterial oxygen tension at 30 and 60 minutes (p < 0 05) and the white cell count and arterial oxygen tension were still reduced at three hours. The coincidence of the fall in PEF at 30 minutes and the fall in arterial oxygen tension suggests that bronchoconstriction might contribute to dialysis induced hypoxaemia by causing ventilation-perfusion disturbances. Appreciable airway dysfunction occurred in all the patients undergoing regular haemodialysis with new cuprophan dialysers and acetate buffered dialysate.
Introduction
This study was undertaken after one patient, with a history of wheeze, developed bronchoconstriction repeatedly during dialysis with a new cuprophan (reconstituted cellulose) dialyser. She required treatment with nebulised salbutamol, intravenous hydrocortisone, and oxygen on each occasion. This dialysis induced asthma resolved when the cuprophan dialyser was changed to one made of polycarbonate.
There have been single case reports of patients who developed bronchoconstriction during haemodialysis," in some cases only when dialysis was carried out with cuprophan dialysers.2 Airway function during haemodialysis has received little attention otherwise. Previous studies of respiratory function have concentrated on defects in gas exchange at the alveolar-capillary membrane3 or on changes in minute ventilation4 or tidal volume,5 in an attempt to explain the hypoxaemia that develops during dialysis with a cuprophan dialyser and against a dialysate buffered with acetate. 6 We decided therefore to measure peak flow rates 23-9 (1 6)t 6-0 (0-6) 187 (12) Fall in peak expiratoryflow during haemodialysis in patients with chronic rengalfailure After 30 minutes PEF increased thi remainder ofdialysis. In 14 patients who for more than four hours, however, there fall in PEF after five hours from 458 (26) min (p = < 0 05 in the comparison wil PEF values).
In the 15 patients whose arterial bloo were available there was a significant f, tension (Pao2) from predialysis values at < of analysis during dialysis, the maximun 60 minutes. There was a positive correla % fall in Pao2 and % fall in PEF at 30 i 0-65, p < 0005). Arterial carbon dio: (Paco2) did not change during dialysis; t bicarbonate increased during dialysis bui was significant only at three hours.
Both the peripheral white blood cell an count fell during the early phase of dial) course of these changes was similar to that for PEF * p< 0.05 and Pao2 (figure). There was no significant correlation between fall in PEF during dialysis and fall in either peripheral white blood cell or platelet count.
Discussion
We have shown a significant fall in peak expiratory flow during the first half hour of dialysis treatment in patients undergoing regular hospital dialysis. The mechanism underlying the reduction in PEF is unknown but is probably related to the bioincompatibility of the dialyser membrane, causing the release of inflammatory mediators.8 This would result in the activation of complement,9 neutrophils,'°m acrophages," and platelets,'2 with the potential for releasing mediators that could cause bronchoconstriction. '3 -i Various allergic reactions, including anaphylaxis, bronchoconstriction, flushing, and hypotension, have been reported in patients during dialysis.'4 Most of these adverse reactions have occurred during dialysis with a new cuprophan dialyser,'5 and have been reported to occur more frequently in patients with greater activation of complement during dialysis. '6 Recently ethylene oxide, a sterilising agent used in the manufacture of both the dialyser and the blood lines, has been reported to cause allergic reactions during dialysis. ' The changes in peak flow rate during dialysis are likely to reflect a balance between the expected roughout the improvement due to the removal of fluid during were dialysed dialysis and bronchoconstriction due to biowas a second incompatibility. Respiratory function tests before and to 410 (30)1/ after dialysis in previous studies have shown an th predialysis increase in both maximal mid expiratory flow rates and PEF, the increase being greater in patients who J gas tensions lost more than 2 kg during dialysis. '9 This suggests that all in oxygen peribronchial oedema before dialysis could be one all three times reason for the low PEF % predicted in our population n fall being at immediately before dialysis. Other causes, such as ition between uraemic skeletal myopathy,/' could also be important.
minutes (r =
The temporal relation between the fall in arterial xide tensions oxygen tension 30 minutes after the start of dialysis the calculated and the fall in PEF suggests that the two might be t this increase linked, possibly as a result of inflammatory mediator release. The fall in Pao2 is unlikely to have been due id the platelet entirely to the fall in PEF, but bronchoconstriction ysis. The time may have aggravated any hypoxaemia by increasing
